Relief Therapeutics Holding SA / Key words: Personnel
Relief Therapeutics Announces CEO Transition
22Nov2023 / 08:40 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Therapeutics Announces CEO Transition
GENEVA NOV. 2... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA / Key words: Miscellaneous
Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
10Oct2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely res... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA / Key words: Half Year Results
Relief Therapeutics Reports HalfYear 2023 Financial Results and Provides Corporate Update
15Sep2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA
/ Key words: Conference
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
01.09.2023 / 07:45 CET/CEST
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA / Key words: Agreement/Product Launch
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ ACER001 with Acer Therapeutics
30Aug2023 / 22:20 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA
/ Key words: Agreement/Product Launch
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health
19.07.2023 / 07:30 CET/CEST
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GO... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA / Key words: Agreement/Product Launch
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, LongTerm, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
23Jun2023 / 07:15 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for t... Lire le communiqué |
|
|
|
|